Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
GT Biopharma, Inc. (GTBP) had Weighted-Average Shares Outstanding (Diluted) of 5.51M for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-34.45M |
|
-- |
|
-- |
|
$12.42M |
|
$-12.42M |
|
$-15.93M |
|
$-28.35M |
|
$-28.35M |
|
$-28.35M |
|
$-28.35M |
|
$-28.35M |
|
$-28.35M |
|
$-12.42M |
|
$-12.42M |
|
5.51M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
5.51M |
$-6.68 |
|
$-6.68 |
|
| Balance Sheet Financials | |
$8.11M |
|
-- |
|
-- |
|
$8.11M |
|
$2.32M |
|
-- |
|
-- |
|
$2.32M |
|
$5.79M |
|
$5.79M |
|
$5.79M |
|
25.53M |
|
| Cash Flow Statement Financials | |
$-12.91M |
|
-- |
|
$15.78M |
|
$4.04M |
|
$6.91M |
|
$2.86M |
|
$0.43M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.50 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-12.91M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-490.04% |
|
-489.96% |
|
-349.79% |
|
-489.96% |
|
$0.23 |
|
$-2.34 |
|
$-2.34 |
|